Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Report 2021

1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Overview

• 1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Scope
• 1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Type
  • 1.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Invokana (Canagliflozin)
  • 1.2.3 Jardiance (Empagliflozin)
  • 1.2.4 Farxiga/Forxiga (Dapagliflozin)
  • 1.2.5 Suglat (Ipragliflozin)
• 1.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Application
  • 1.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital
  • 1.3.3 Medical Research Institute
  • 1.3.4 Other
• 1.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Trends (2016-2027)

2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Estimates and Forecasts by Region

• 2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2016-2021)
• 2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Estimates and Projections (2016-2027)
  • 2.4.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Estimates and Projections (2016-2027)
  • 2.4.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Estimates and Projections (2016-2027)
  • 2.4.4 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Estimates and Projections (2016-2027)
  • 2.4.6 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Estimates and Projections (2016-2027)

3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Competition Landscape by Players

• 3.1 Global Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players by Sales (2016-2021)
• 3.2 Global Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players by Revenue (2016-2021)
• 3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors as of 2020)
• 3.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Price by Company (2016-2021)
• 3.5 Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type

• 4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2016-2021)
• 4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Type (2022-2027)

5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application

• 5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2016-2021)
• 5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application (2022-2027)

6 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures

• 6.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company
  • 6.1.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2016-2021)
  • 6.1.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2016-2021)
• 6.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type
  • 6.2.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2022-2027)
• 6.3 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application
  • 6.3.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2022-2027)

7 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures

• 7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company
  • 7.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2016-2021)
  • 7.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2016-2021)
• 7.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type
  • 7.2.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2022-2027)
• 7.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application
  • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures

• 8.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company
  • 8.1.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2016-2021)
  • 8.1.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2016-2021)
• 8.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type
  • 8.2.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2022-2027)
• 8.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application
  • 8.3.1 China 245 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures

• 9.1 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company
  • 9.1.1 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2016-2021)
  • 9.1.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2016-2021)
• 9.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type
  • 9.2.1 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2022-2027)
• 9.3 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures

• 10.1 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company
  • 10.1.1 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2016-2021)
• 10.2 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type
  • 10.2.1 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application
  • 10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)

11 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures

• 11.1 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company
  • 11.1.1 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2016-2021)
  • 11.1.2 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2016-2021)
• 11.2 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type
  • 11.2.1 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2022-2027)
• 11.3 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application
  • 11.3.1 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business

• 12.1 Eli Lilly
  • 12.1.1 Eli Lilly Corporation Information
  • 12.1.2 Eli Lilly Business Overview
  • 12.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
  • 12.1.5 Eli Lilly Recent Development
• 12.2 Janssen Pharmaceuticals
  • 12.2.1 Janssen Pharmaceuticals Corporation Information
  • 12.2.2 Janssen Pharmaceuticals Business Overview
  • 12.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
  • 12.2.5 Janssen Pharmaceuticals Recent Development
• 12.3 Astellas
  • 12.3.1 Astellas Corporation Information
  • 12.3.2 Astellas Business Overview
  • 12.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
  • 12.3.5 Astellas Recent Development
• 12.4 Boehringer Ingelheim
  • 12.4.1 Boehringer Ingelheim Corporation Information
  • 12.4.2 Boehringer Ingelheim Business Overview
  • 12.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
  • 12.4.5 Boehringer Ingelheim Recent Development
• 12.5 AstraZeneca
  • 12.5.1 AstraZeneca Corporation Information
  • 12.5.2 AstraZeneca Business Overview
  • 12.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
  • 12.5.5 AstraZeneca Recent Development
• 12.6 Bristol Myers Squibb
  • 12.6.1 Bristol Myers Squibb Corporation Information
  • 12.6.2 Bristol Myers Squibb Business Overview
  • 12.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
  • 12.6.5 Bristol Myers Squibb Recent Development
• 12.7 Kotobuki Pharmaceutical
  • 12.7.1 Kotobuki Pharmaceutical Corporation Information
  • 12.7.2 Kotobuki Pharmaceutical Business Overview
  • 12.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
  • 12.7.5 Kotobuki Pharmaceutical Recent Development

...

13 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Cost Analysis

• 13.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
• 13.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List
• 14.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers

15 Market Dynamics

• 15.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trends
• 15.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Drivers
• 15.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Challenges
• 15.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List